#immunotherapy-resistant-cancer

[ follow ]
Medicine
fromwww.theguardian.com
1 day ago

Smart jab can shrink head and neck cancer tumours within six weeks, trial finds

Amivantamab injections rapidly shrank tumours in recurrent or metastatic head and neck squamous cell carcinoma patients within six weeks in a multinational trial.
[ Load more ]